N-acetylcysteine in Alcohol Dependence

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Alcoholism
Interventions
DRUG

N-acetylcysteine

Patients will take oral N-acetylcysteine 900 mg/day for 1 week, 1800 mg/day for 1 week, 2700 mg/day for 1 week, and then 3600 mg/day.

DRUG

Placebo

Patients will take oral placebo (identical matching placebo) during the study period.

Trial Locations (1)

55417

Minneapolis VA Medical Center, Minneapolis

All Listed Sponsors
collaborator

Minnesota Veterans Medical Research and Education Foundation

OTHER

lead

Minneapolis Veterans Affairs Medical Center

FED

NCT00568087 - N-acetylcysteine in Alcohol Dependence | Biotech Hunter | Biotech Hunter